Content
All Posts > Content under IPOs Education
Israeli Startup Deal Digest – June 2020
Article By:
Shelly Hod Moyal
Read
Thursday, July 16, 2020 5:04 AM EDT
This June we tracked 27 announced deals totaling approximately $560 Million, and 8 exits worth over $1.5 Billion.
The Week Ahead In Biotech: J&J Kickstarts Pharma Earnings, Repare Therapeutics IPO
Article By:
Benzinga
Read
Sunday, July 12, 2020 3:17 PM EDT
Biotech stocks advanced in the week ended July 10 amid mixed news emerging out of the sector. FDA approved a few drugs, including Endo International PLC's cellulite treatment, while Merck & Co. & Eisai Co.'s combo therapy was rejected by the FDA.
Week In Review: Ocumension Climbs To $2.5 Billion Market Cap After $184 Million Hong Kong IPO
Article By:
ChinaBio® Today
Read
Saturday, July 11, 2020 12:05 PM EDT
Ocumension, a Shanghai ophthalmic pharma, completed a $184 million Hong Kong IPO and climbed 152% in its first trading session, giving the company a valuation of about $2.5 billion. The company has raised $200 million in venture capital.
Week In Review: China Life Science Announces Deals Worth $1.3 Billion
Article By:
ChinaBio® Today
Read
Saturday, July 4, 2020 4:09 PM EDT
Boehringer Ingelheim launched its External Innovation Hub China in Shanghai to increase the company's China R&D partnerships.. The Hub has $508 million to spend on China clinical research, expansion of production sites and research partnerships.
In this article: BNR
How To Pick The Next Billion-Dollar Company
Article By:
Money Morning
Read
Saturday, July 4, 2020 12:44 PM EDT
Here's the thing about being a thematic investor: There's a small chance you will be very rich, and close to a 100% chance you will lose all your capital. The strategy I prefer is an investment style called generalist investing.
8 Stock Catalysts For The Week Ahead
Pending Clinical Readouts In Focus During A Short Holiday Week
Article By:
Benzinga
Read
Sunday, June 28, 2020 3:03 PM EDT
Biotech stocks went on a seesaw ride along with the broader markets in the week ending June 26. Yet, there were some encouraging developments on the COVID-19 vaccine development front. Vaccine companies are going all out.
In this article: SNY, TBIO, VXRT, ALXN, NVAX, RVNC, ITCI, ZYNE, OBSV, ITRM, NVS, CERC, RGNX, BNTX, INO, CDMO, CALT
Week In Review: VistaGen Out-Licenses China/Asia Rights For Novel Anxiety Drug To EverInsight In $177 Million Deal
Article By:
ChinaBio® Today
Read
Saturday, June 27, 2020 2:00 PM EDT
VistaGen of South San Francisco out-licensed China/Southeast Asia rights for a novel anxiety treatment to EverInsight Therapeutics, a China in-licensing company, in a $177 million agreement.